Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has issued an update.
Proteomics International Laboratories Ltd has announced the quotation of 50,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code PIQ. This move is part of the company’s ongoing efforts to enhance its market presence and provide additional value to its stakeholders by leveraging its expertise in proteomics.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests and analytical services. The company is known for its innovative solutions in proteomics, which involve the study of proteins to understand biological processes and diseases.
Average Trading Volume: 284,973
Technical Sentiment Signal: Sell
Current Market Cap: A$54.83M
Find detailed analytics on PIQ stock on TipRanks’ Stock Analysis page.